摘要
视网膜变性疾病是一组由视网膜光感受器细胞变性、凋亡所致的严重致盲性眼病,至今仍无彻底的根治方法。多潜能干细胞是一种通过将体细胞重编程为类似胚胎干细胞的多潜能细胞,具有无限增殖、多向分化潜能和记忆能力等特点。目前有不少研究者将多潜能干细胞诱导分化为视网膜细胞,并应用于视网膜疾病的细胞移植治疗、发病机制研究及药物毒性评价等方面,这将为视网膜变性疾病的治疗提供新的研究思路和方法。
Retinal degeneration diseases are a group of severe eye diseases that can lead to blindness. They are characterized by degeneration and apoptosis of photoreceptor cells and still lacking effective therapeutic procedures. Pluripotent stem cells (induced pluripotent stem cells, iPS cells) obtained from somatic cell reprogramming are similar to the embryonic stem cells (embryonic stem cells, ES cells ) , which have unlimited proliferation, differentiation and memory characteristics. Retinal cells from iPS cells have been used in cell transplantation for the treatment of retinal diseases, for the study of pathogenesis and drug toxicity evaluation in retinal degenerative diseases. This may provide new ideas and novel procedures for the treatment of retinal degenerative diseases in the future.
出处
《中华眼科杂志》
CAS
CSCD
北大核心
2012年第4期374-378,共5页
Chinese Journal of Ophthalmology
关键词
视网膜变性
多潜能干细胞
细胞移植
药物评价
Retinal degeneration
Induced pluripotent stem cells
Cell transplantation
Drug evaluation